BIIB vs HUBS · P/E 21, rev $9.89B vs P/E 96, rev $1.79B
Biogen Inc (BIIB) versus HubSpot Inc (HUBS) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
HubSpot Inc (HUBS) is a software - application company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported HUBS revenue for 2026-06-30 was $1.79B. Net income was $75.9M. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. HUBS currently screens at market cap $9.36B and trailing P/E 96.2.
Not investment advice. Open the BIIB and HUBS stock pages for the full models.
Not investment advice.